0001104659-22-079650.txt : 20220713 0001104659-22-079650.hdr.sgml : 20220713 20220713213102 ACCESSION NUMBER: 0001104659-22-079650 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220623 FILED AS OF DATE: 20220713 DATE AS OF CHANGE: 20220713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mertz Larry Michael CENTRAL INDEX KEY: 0001938051 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31822 FILM NUMBER: 221082117 MAIL ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD CITY: TUCSON STATE: AZ ZIP: 85714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc CENTRAL INDEX KEY: 0000727207 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 841072256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 BUSINESS PHONE: 303-863-8088 MAIL ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 FORMER COMPANY: FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: HYDRO SEEK INC DATE OF NAME CHANGE: 19880802 3 1 tm2220329d1_3.xml OWNERSHIP DOCUMENT X0206 3 2022-06-23 0 0000727207 Accelerate Diagnostics, Inc AXDX 0001938051 Mertz Larry Michael C/O ACCELERATE DIAGNOSTICS, INC. 3950 S. COUNTRY CLUB ROAD, SUITE 470 TUCSON AZ 85714 0 1 0 0 Chief Technology Officer Common Stock 331662 D Employee Restricted Stock Units Common Stock 25671 D Employee Restricted Stock Units Common Stock 71642 D Employee Stock Option (right to buy) 7.09 2031-05-30 Common Stock 100000 D The reporting person received an aggregate of 38,507 restricted stock units on May 20, 2021, of which 1/3 vested on May 20, 2022 and the remaining 2/3 will vest in two approximately equal installments on May 20, 2023 and May 20, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Not applicable. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The reporting person received 71,642 restricted stock units on April 4, 2022, of which 40% vests on April 4, 2024 and the remaining 60% will vest on April 4, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. The reporting person received a stock option to purchase 100,000 shares of the issuer's common stock on May 20, 2021, of which 1/3 vested on May 20, 2022 and the remaining 2/3 will vest in two approximately equal installments on May 20, 2023 and May 20, 2024. Exhibit List: Exhibit 24 - Power of Attorney /s/ Steve Reichling, attorney-in-fact 2022-07-13 EX-24 2 tm2220329d1_ex24.htm EXHIBIT 24

 

EXHIBIT 24

 

ACCELERATE DIAGNOSTICS, INC.

 

LIMITED POWER OF ATTORNEY

FOR SECTION 16 REPORTING OBLIGATIONS

 

Know all by these presents that the undersigned hereby makes, constitutes, and appoints Steve Reichling, Michael Bridge and Chris Simon (or any of them acting alone) as the undersigned’s true and lawful attorney-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to:

 

(1)prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the “Exchange Act”);

 

(2)prepare and execute Forms 3, 4 and 5 (including any amendments thereto) with respect to the securities of Accelerate Diagnostics, Inc., a Delaware corporation (the “Company”), and to file the same with the U.S. Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Exchange Act and the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”); and

 

(3)seek or obtain, as the undersigned’s representative and on the undersigned’s behalf, information on transactions in the Company’s securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information.

 

The undersigned acknowledges that:

 

(a)any documents prepared and/or executed by any of such attorney-in-fact on behalf of the undersigned pursuant to this power of attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable;

 

(b)this power of attorney authorizes, but does not require, such attorney-in-fact to act in his or her discretion on information provided to such attorney-in-fact without independent verification of such information;

 

1

 

 

(c)neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned’s responsibility to comply with the requirements of the Securities Act of 1933, as amended (the “Securities Act”), the Exchange Act or the Sarbanes-Oxley Act (as applicable), (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and

 

(d)this power of attorney does not relieve the undersigned from responsibility for compliance with the undersigned’s obligations under the Securities Act and the Exchange Act, including, but not limited to, the reporting requirements under Section 16(a) of the Exchange Act.

 

The undersigned hereby gives and grants the foregoing attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorney-in-fact of, for and on behalf of the undersigned shall lawfully do or cause to be done by virtue of this power of attorney.

 

This power of attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company. This power of attorney also serves to revoke and replace as of the date hereof, any prior power of attorney executed by the undersigned with respect to the matters stated herein.

 

[SIGNATURE PAGE FOLLOWS]

 

2

 

 

IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of the date set forth below.

 

  /s/ Larry Mertz
  Larry Mertz
                                      
  Date: 6/27/2022

 

3